• 1. Estimation of hydrogen sulfide from crude petroleum: a unique invention using a simple chemosensor?
  Shampa Kundu,Prithidipa Sahoo New J. Chem., 2019,43, 12369-12374
• 2. Evidence of pre-micellar aggregates in aqueous solution of amphiphilic PDMS–PEO block copolymer?
  Domenico Lombardo,Gianmarco Munaò,Pietro Calandra,Luigi Pasqua,Maria Teresa Caccamo Phys. Chem. Chem. Phys., 2019,21, 11983-11991
• 3. Estimating and correcting interference fringes in infrared spectra in infrared hyperspectral imaging
  Ghazal Azarfar,Ebrahim Aboualizadeh,Nicholas M. Walter,Simona Ratti,Camilla Olivieri,Alessandra Norici,Michael Nasse,Achim Kohler,Mario Giordano Analyst, 2018,143, 4674-4683
• 4. Elusive 2-aminofuran Diels–Alder substrates for a straightforward synthesis of polysubstituted anilines?
  Ana G. Neo,Ana Bornadiego,Jesús Díaz,Stefano Marcaccini,Carlos F. Marcos Org. Biomol. Chem., 2013,11, 6546-6555
• 5. Distribution pattern and allocation of defects in hydrogenated ZnO thin films?
  Vitaly Gurylev,Chung-Yi Su,Tsong-Pyng Perng Phys. Chem. Chem. Phys., 2016,18, 16033-16038

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Diazinanes Piperazines N-arylpiperazines

Introduction to 4-chloro-2-methyl-6-(piperazin-1-yl)pyrimidine (CAS No. 1000843-24-2)

4-chloro-2-methyl-6-(piperazin-1-yl)pyrimidine, identified by the CAS number 1000843-24-2, is a significant intermediate in modern pharmaceutical synthesis. This compound belongs to the pyrimidine class, which is well-documented for its broad spectrum of biological activities and pharmaceutical applications. The structural features of this molecule, particularly the presence of a chloro substituent at the 4-position, a methyl group at the 2-position, and a piperazine moiety at the 6-position, contribute to its versatility in drug development.

The pyrimidine core is a fundamental scaffold in medicinal chemistry, playing a crucial role in the design of nucleoside analogs, antiviral agents, and anticancer drugs. The introduction of various substituents into this core structure allows for fine-tuning of pharmacological properties, including solubility, bioavailability, and target specificity. In the case of 4-chloro-2-methyl-6-(piperazin-1-yl)pyrimidine, the chloro group enhances electrophilicity, making it a valuable precursor for further functionalization via nucleophilic substitution reactions. The methyl group at the 2-position influences steric hindrance and electronic distribution, while the piperazine ring introduces basicity and hydrogen bonding capabilities, which are critical for interactions with biological targets.

Recent advancements in drug discovery have highlighted the importance of heterocyclic compounds like pyrimidines in addressing unmet medical needs. 4-chloro-2-methyl-6-(piperazin-1-yl)pyrimidine has been extensively studied as a building block for synthesizing novel therapeutic agents. Its utility extends to the development of kinase inhibitors, which are pivotal in treating cancers and inflammatory diseases. The piperazine moiety, in particular, has shown promise in modulating protein-protein interactions and enzyme activity, making it a preferred choice for medicinal chemists seeking to design targeted therapies.

One notable application of this compound is in the synthesis of small-molecule inhibitors targeting tyrosine kinases. Tyrosine kinases are overexpressed or mutated in numerous cancers, leading to aberrant signaling pathways that drive tumor growth and progression. By incorporating 4-chloro-2-methyl-6-(piperazin-1-yl)pyrimidine into drug candidates, researchers have been able to develop potent inhibitors that selectively inhibit these kinases without significant off-target effects. For instance, derivatives of this compound have been investigated as potential treatments for chronic myeloid leukemia (CML), where imatinib mesylate (a well-known tyrosine kinase inhibitor) was originally inspired by similar structural motifs.

The role of 4-chloro-2-methyl-6-(piperazin-1-yl)pyrimidine in antiviral research is equally compelling. Pyrimidine-based compounds have long been recognized for their antiviral properties, particularly against RNA viruses such as HIV and hepatitis C virus (HCV). The ability to modify the pyrimidine core with functional groups like chloro and piperazine allows for the creation of molecules that can interfere with viral replication cycles. Recent studies have demonstrated that analogs of this compound can inhibit viral proteases and polymerases, thereby reducing viral load in infected individuals. The versatility of 4-chloro-2-methyl-6-(piperazin-1-yl)pyrimidine as a scaffold enables medicinal chemists to explore diverse chemical spaces, leading to the discovery of next-generation antiviral agents.

In addition to its applications in oncology and virology, 4-chloro-2-methyl-6-(piperazin-1-yl)pyrimidine has shown potential in addressing neurological disorders. Piperazine derivatives are known for their ability to cross the blood-brain barrier, making them suitable candidates for central nervous system (CNS) drug development. Research has indicated that modifications at the 4-chloro and piperazine positions can enhance pharmacokinetic properties, improving therapeutic efficacy while minimizing side effects. This has spurred interest in developing novel treatments for neurodegenerative diseases such as Alzheimer's and Parkinson's disease, where modulation of kinase activity and neurotransmitter systems is crucial.

The synthetic chemistry associated with 4-chloro-2-methyl-6-(piperazin-1-yl)pyrimidine is equally fascinating. The compound serves as a versatile intermediate that can be further functionalized through various organic transformations. For example, nucleophilic aromatic substitution reactions at the 4-chloro position allow for the introduction of diverse substituents, including amino groups for subsequent coupling reactions or other pharmacophores. Additionally, palladium-catalyzed cross-coupling reactions can be employed to extend or modify the pyrimidine ring system. These synthetic strategies have enabled researchers to generate libraries of derivatives rapidly, facilitating high-throughput screening programs aimed at identifying lead compounds with optimized pharmacological profiles.

The impact of computational methods on the design and optimization of 4-chloro-2-methyl-6-(piperazin-1-y l)pyrimidine derivatives cannot be overstated. Molecular modeling techniques such as docking simulations and quantum mechanical calculations have become indispensable tools in modern drug discovery. By predicting binding affinities and interactions between drug candidates and biological targets, these methods allow researchers to rationalize structural modifications that enhance potency and selectivity. Furthermore, virtual screening algorithms enable high-throughput analysis of large compound databases, identifying promising candidates like 4-chloro -2-methyl -6-( piperazin -1 - yl ) pyrimidine for further experimental validation.

Emerging trends in pharmaceutical research continue to drive innovation around 4-chloro -2 -methyl -6-( piperazin -1 - yl ) pyrimidine . One notable trend is the integration of machine learning models into drug development pipelines. These models can predict physicochemical properties and biological activities based on structural features alone, significantly accelerating lead optimization processes. Another trend is the focus on green chemistry principles—developing synthetic routes that minimize waste generation and hazardous reagent usage while maintaining high yields and purity standards; this aligns with broader sustainability goals within the pharmaceutical industry.

The future prospects for 4-chloro -2 -methyl -6-( piperazin -1 - yl ) pyrimidine are promising given its broad applicability across multiple therapeutic areas . As our understanding of disease mechanisms evolves , so too will our ability to leverage this compound as a scaffold for novel therapeutics . Whether through traditional wet chemistry approaches or cutting-edge computational methods , researchers will continue exploring new ways this versatile molecule can contribute toward improving human health outcomes worldwide。

• 101080-47-1(4,6-Pyrimidinediamine,N4-ethyl-)
• 14538-81-9(N4,2-dimethylpyrimidine-4,6-diamine)
• 109397-74-2(1,2-Ethanediamine,N1,N1-diethyl-N2-(6-methyl-4-pyrimidinyl)-N2-(phenylmethyl)-)
• 252722-52-4(4-piperazin-1-yl-7H-pyrrolo2,3-dpyrimidine)
• 141071-86-5(5-Methoxy-4-(piperazin-1-yl)pyrimidine)
• 131816-67-6(2-methyl-4-(piperazin-1-yl)pyrimidine)
• 111641-17-9(4-(Piperazin-1-yl)-2,6-di(pyrrolidin-1-yl)pyrimidine)
• 91717-22-5(2-Amino-4-piperidino-6-methylpyrimidine)
• 24867-26-3(2,4-Diamino-6-piperidinopyrimidine (Desoxyminoxidil))
• 914347-48-1(2-(4-(6-amino-2-methylpyrimidin-4-yl)piperazin-1-yl)ethan-1-ol)